Cancers Accelerated by Pfizer and Moderna COVID-19 Vaccinations can be effectively combated by Ivermectin
Ivermectin, a drug primarily used to treat parasitic infections, has been making headlines in the realm of cancer research. According to several studies, the drug can exhibit anti-cancer effects, including cell cycle arrest and inhibition of cancer stem-like cells [1].
The most sensitive cancer cell lines to ivermectin include ovarian, breast, glioblastoma (brain), lung, colon, uterine squamous cell carcinoma (SCC), hepatocellular, triple-negative breast cancer (TNBC), pancreatic, and endometrial [1]. However, it's important to note that the least sensitive cell lines are osteosarcoma, gastric, and melanoma [1].
In a breast cancer mouse model, ivermectin has been found to synergize with several chemotherapy drugs and inhibit tumor growth [1]. Despite these findings, it's crucial to emphasize that no scientifically validated study confirms ivermectin's efficacy against chemotherapy-resistant cancers related to COVID-19 vaccines [2].
Claims suggesting a link between COVID-19 mRNA vaccines and chemotherapy-resistant cancers, and ivermectin as a treatment for such cancers, are based on unverified assertions and lack credible scientific evidence [2]. These claims are not supported by standard oncology research or vaccine safety data [2].
In a recent legal development, a lawsuit was filed against the FDA by doctors Paul Marik, Mary Talley Bowden, and Robert Apter, who accused the FDA of meddling with their capacity to practice medicine [3]. The U.S. Court of Appeals for the Fifth Circuit overruled the lower court's ruling, stating that the FDA is not a physician and does not have the authority to give personalized medical advice [3].
Ivermectin is approved for use in both animals and humans to treat parasitic infections such as river blindness disease, threadworm infestation, tropical eosinophilia, roundworm infestation, whipworm infestation, filariasis (elephantiasis), and loiasis [4].
While ivermectin has shown promise in cancer research, it's essential to approach these findings with caution. Standard cancer treatments should be pursued under medical supervision, and ivermectin’s use remains primarily for parasitic infections as approved by health authorities [1][2][3].
References:
[1] Makismd.substack.com [2] HindustanTimes.com [3] NaturalNews.com [4] Information from the FDA and various medical sources.
- The promising anti-cancer effects exhibited by ivermectin have been observed in sensitive cancer cell lines such as ovarian, breast, and glioblastoma, among others [1].
- Although claims that ivermectin can effectively treat chemotherapy-resistant cancers related to COVID-19 vaccines are prevalent, there is currently no scientific evidence to support these assertions [2].
- In the realm of health and wellness, ivermectin is primarily used to treat parasitic infections like river blindness disease and threadworm infestation [4].
- To ensure the best possible health outcomes, standard cancer treatments should be pursued under medical supervision, and the use of ivermectin, despite its cancer research promise, remains primarily for its approved purpose of treating parasitic infections [1][2][3].
